Anixa Operating Income vs Net Income From Continuing Ops Analysis

ANIX Stock

USD 3.14 0.01 0.32%

Anixa Biosciences financial indicator trend analysis is way more than just evaluating Anixa Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anixa Biosciences is a good investment. Please check the relationship between Anixa Biosciences Operating Income and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Operating Income vs Net Income From Continuing Ops

Operating Income vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anixa Biosciences Operating Income account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Anixa Biosciences' Operating Income and Net Income From Continuing Ops is 0.91. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Anixa Biosciences, assuming nothing else is changed. The correlation between historical values of Anixa Biosciences' Operating Income and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Anixa Biosciences are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Operating Income i.e., Anixa Biosciences' Operating Income and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Anixa Biosciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Anixa Biosciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Net Income From Continuing Ops

Most indicators from Anixa Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.At this time, Anixa Biosciences' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 28.31 in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 2.5 M in 2025.

Anixa Biosciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Currrent Assets Other	Net Receivables	Accounts Payable	Non Current Liabilities Total	Common Stock Total Equity	Short Term Investments	Common Stock	Other Assets	Property Plant Equipment
Total Assets		0.76	0.43	0.98	0.5	-0.6	-0.7	0.57	-0.54	0.99	0.85	0.21	0.31	0.79	-0.28	0.5	0.99	-0.2	-0.37	-0.35	-0.53	-0.33	0.79	-0.32	-0.24	0.63
Other Current Liab	0.76		0.73	0.75	0.33	-0.07	-0.72	0.01	-0.54	0.75	0.91	0.05	0.55	0.86	-0.19	0.33	0.77	-0.19	-0.34	0.07	-0.54	-0.16	0.92	-0.15	-0.26	0.53
Total Current Liabilities	0.43	0.73		0.32	-0.1	0.23	-0.53	-0.2	0.05	0.36	0.59	0.12	0.35	0.62	0.4	-0.1	0.39	-0.2	-0.46	0.31	0.02	0.34	0.64	0.35	-0.41	0.09
Total Stockholder Equity	0.98	0.75	0.32		0.58	-0.63	-0.68	0.58	-0.68	0.99	0.86	0.13	0.36	0.78	-0.45	0.58	0.99	-0.2	-0.3	-0.38	-0.68	-0.45	0.78	-0.45	-0.15	0.7
Property Plant And Equipment Net	0.5	0.33	-0.1	0.58		-0.38	-0.09	0.36	-0.73	0.56	0.4	0.03	0.45	0.2	-0.58	1.0	0.55	-0.16	0.33	-0.39	-0.65	-0.53	0.4	-0.53	0.5	0.94
Net Debt	-0.6	-0.07	0.23	-0.63	-0.38		0.22	-0.98	0.38	-0.63	-0.27	0.06	0.02	-0.21	0.42	-0.38	-0.6	0.11	0.17	0.51	0.39	0.26	0.0	0.26	0.02	-0.32
Retained Earnings	-0.7	-0.72	-0.53	-0.68	-0.09	0.22		-0.21	0.41	-0.69	-0.85	0.16	-0.52	-0.93	0.12	-0.09	-0.7	0.08	0.82	-0.21	0.36	0.35	-0.69	0.35	0.75	-0.23
Cash	0.57	0.01	-0.2	0.58	0.36	-0.98	-0.21		-0.3	0.6	0.23	-0.02	-0.08	0.18	-0.29	0.36	0.57	-0.03	-0.21	-0.48	-0.28	-0.2	-0.04	-0.21	-0.06	0.29
Non Current Assets Total	-0.54	-0.54	0.05	-0.68	-0.73	0.38	0.41	-0.3		-0.63	-0.66	0.31	-0.56	-0.49	0.87	-0.73	-0.63	0.0	-0.06	0.26	0.94	0.75	-0.53	0.75	-0.22	-0.77
Cash And Short Term Investments	0.99	0.75	0.36	0.99	0.56	-0.63	-0.69	0.6	-0.63		0.86	0.15	0.34	0.78	-0.37	0.56	1.0	-0.18	-0.34	-0.37	-0.61	-0.4	0.77	-0.4	-0.19	0.67
Common Stock Shares Outstanding	0.85	0.91	0.59	0.86	0.4	-0.27	-0.85	0.23	-0.66	0.86		-0.08	0.6	0.96	-0.34	0.4	0.87	-0.24	-0.5	-0.04	-0.64	-0.44	0.88	-0.44	-0.37	0.6
Inventory	0.21	0.05	0.12	0.13	0.03	0.06	0.16	-0.02	0.31	0.15	-0.08		-0.44	-0.05	0.28	0.03	0.15	0.1	0.28	-0.03	0.23	0.21	0.21	0.21	0.11	0.06
Other Current Assets	0.31	0.55	0.35	0.36	0.45	0.02	-0.52	-0.08	-0.56	0.34	0.6	-0.44		0.54	-0.33	0.45	0.36	-0.21	-0.29	0.27	-0.49	-0.38	0.48	-0.38	-0.17	0.54
Other Stockholder Equity	0.79	0.86	0.62	0.78	0.2	-0.21	-0.93	0.18	-0.49	0.78	0.96	-0.05	0.54		-0.18	0.2	0.8	-0.13	-0.68	0.14	-0.45	-0.39	0.83	-0.38	-0.6	0.41
Total Liab	-0.28	-0.19	0.4	-0.45	-0.58	0.42	0.12	-0.29	0.87	-0.37	-0.34	0.28	-0.33	-0.18		-0.58	-0.37	0.02	-0.25	0.31	0.92	0.75	-0.2	0.75	-0.35	-0.57
Property Plant And Equipment Gross	0.5	0.33	-0.1	0.58	1.0	-0.38	-0.09	0.36	-0.73	0.56	0.4	0.03	0.45	0.2	-0.58		0.55	-0.16	0.33	-0.39	-0.65	-0.53	0.4	-0.53	0.5	0.94
Total Current Assets	0.99	0.77	0.39	0.99	0.55	-0.6	-0.7	0.57	-0.63	1.0	0.87	0.15	0.36	0.8	-0.37	0.55		-0.19	-0.33	-0.35	-0.61	-0.4	0.8	-0.4	-0.19	0.68
Non Currrent Assets Other	-0.2	-0.19	-0.2	-0.2	-0.16	0.11	0.08	-0.03	0.0	-0.18	-0.24	0.1	-0.21	-0.13	0.02	-0.16	-0.19		0.09	0.37	0.11	-0.1	-0.19	-0.1	-0.06	-0.19
Net Receivables	-0.37	-0.34	-0.46	-0.3	0.33	0.17	0.82	-0.21	-0.06	-0.34	-0.5	0.28	-0.29	-0.68	-0.25	0.33	-0.33	0.09		-0.35	-0.09	0.06	-0.26	0.06	0.95	0.23
Accounts Payable	-0.35	0.07	0.31	-0.38	-0.39	0.51	-0.21	-0.48	0.26	-0.37	-0.04	-0.03	0.27	0.14	0.31	-0.39	-0.35	0.37	-0.35		0.26	0.14	-0.08	0.15	-0.5	-0.36
Non Current Liabilities Total	-0.53	-0.54	0.02	-0.68	-0.65	0.39	0.36	-0.28	0.94	-0.61	-0.64	0.23	-0.49	-0.45	0.92	-0.65	-0.61	0.11	-0.09	0.26		0.67	-0.52	0.67	-0.24	-0.69
Common Stock Total Equity	-0.33	-0.16	0.34	-0.45	-0.53	0.26	0.35	-0.2	0.75	-0.4	-0.44	0.21	-0.38	-0.39	0.75	-0.53	-0.4	-0.1	0.06	0.14	0.67		-0.31	1.0	-0.02	-0.56
Short Term Investments	0.79	0.92	0.64	0.78	0.4	0.0	-0.69	-0.04	-0.53	0.77	0.88	0.21	0.48	0.83	-0.2	0.4	0.8	-0.19	-0.26	-0.08	-0.52	-0.31		-0.3	-0.19	0.61
Common Stock	-0.32	-0.15	0.35	-0.45	-0.53	0.26	0.35	-0.21	0.75	-0.4	-0.44	0.21	-0.38	-0.38	0.75	-0.53	-0.4	-0.1	0.06	0.15	0.67	1.0	-0.3		-0.02	-0.56
Other Assets	-0.24	-0.26	-0.41	-0.15	0.5	0.02	0.75	-0.06	-0.22	-0.19	-0.37	0.11	-0.17	-0.6	-0.35	0.5	-0.19	-0.06	0.95	-0.5	-0.24	-0.02	-0.19	-0.02		0.38
Property Plant Equipment	0.63	0.53	0.09	0.7	0.94	-0.32	-0.23	0.29	-0.77	0.67	0.6	0.06	0.54	0.41	-0.57	0.94	0.68	-0.19	0.23	-0.36	-0.69	-0.56	0.61	-0.56	0.38

Click cells to compare fundamentals

Anixa Biosciences Account Relationship Matchups

Anixa Biosciences fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	36.3M	30.4M	25.5M	21.6M	24.8M	26.1M
Other Current Liab	1.1M	1.7M	1.8M	1.9M	2.2M	2.3M
Total Current Liabilities	1.3M	2.0M	2.0M	2.5M	2.9M	3.0M
Total Stockholder Equity	35.4M	29.0M	24.3M	20.0M	23.0M	24.1M
Property Plant And Equipment Net	254.0K	212K	166K	229K	206.1K	133.4K
Net Debt	(28.9M)	(12.1M)	(740K)	(1.0M)	(935.1K)	(981.9K)
Retained Earnings	(204.8M)	(218.4M)	(228.2M)	(240.8M)	(216.7M)	(205.8M)
Cash	29.1M	12.4M	915K	1.3M	1.5M	1.4M
Non Current Assets Total	254.0K	212K	166K	229K	263.4K	250.2K
Cash And Short Term Investments	35.7M	29.7M	23.8M	19.9M	22.9M	24.1M
Common Stock Shares Outstanding	28.6M	30.4M	31.0M	31.9M	36.7M	38.5M
Liabilities And Stockholders Equity	36.3M	30.4M	25.5M	21.6M	24.8M	26.1M
Other Current Assets	551.6K	513K	1.2M	1.3M	1.1M	1.2M
Other Stockholder Equity	239.9M	247.1M	252.2M	260.4M	299.5M	314.5M
Total Liab	1.5M	2.2M	2.2M	2.7M	3.1M	2.3M
Property Plant And Equipment Gross	254.0K	212K	166K	229K	206.1K	133.4K
Total Current Assets	36.0M	30.2M	25.4M	21.4M	24.6M	25.8M
Accounts Payable	136K	265K	206K	525K	472.5K	415.3K
Non Current Liabilities Total	220.1K	175K	123K	203K	233.5K	221.8K
Short Term Investments	6.6M	17.3M	22.9M	18.7M	21.5M	22.5M
Common Stock	300.5K	309K	311K	322K	289.8K	275.3K
Property Plant Equipment	200.6K	54.3K	254.0K	212K	243.8K	256.0K
Short Long Term Debt Total	259.5K	221K	175K	232K	208.8K	198.4K
Net Tangible Assets	5.2M	8.8M	35.4M	29.0M	33.4M	35.1M
Short Term Debt	78.4K	92K	52K	29K	26.1K	24.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Anixa Operating Income vs Net Income From Continuing Ops Analysis

Operating Income vs Net Income From Continuing Ops

Operating Income vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Operating Income

Net Income From Continuing Ops

Anixa Biosciences fundamental ratios Correlations

Anixa Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Anixa Biosciences fundamental ratios Accounts

Also Currently Popular

Additional Tools for Anixa Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.93	Retained Earnings
Common Stock Shares Outstanding	- 0.85	Retained Earnings
Property Plant Equipment	- 0.77	Non Current Assets Total
Property Plant And Equipment Gross	- 0.73	Non Current Assets Total
Non Current Assets Total	- 0.73	Property Plant And Equipment Net